To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

Johnson & Johnson has proposed to pay almost $9bn to resolve tens of thousands of lawsuits it faces in North America that claim its baby powder and other talc-based products cause cancer.

Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is ... for mother and babies. Johnson's Baby Powder also went ...

Oct 15 (Reuters) - Johnson & Johnson (JNJ.N), opens ... Plaintiffs in all of the lawsuits say that J&J's talc products, like its once iconic baby powder, were tainted with asbestos, a carcinogen ...

But Were in 'No Rush to Get Married' Dakota Johnson Recalls 'Healthy' Sex Talks with Mom Melanie Griffith: 'At Times Maybe Too Open' Dakota Johnson Says She's 'So Open' to Becoming a Mom ...

That’s why many parents and caregivers use baby lotion to soothe the skin of their little ones. Of course, you don’t want to pick up just any baby lotion; you want a baby lotion you know will ...

It was originally formed in 1866 when three brothers (Robert, Edward, and James Johnson) founded the company to focus on producing bandages and baby products. It has since grown into one of the ...

In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...

All products ... Is Dakota Johnson about to become a bagfluencer? Amid a sea of look-at-me designer pieces decked out in flashy keychains (a.k.a. bagmaxxing), the Loser Baby director keeps ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE ... with a steady demand for products and services due to the biological nature of humans. Stocks like Pfizer Inc ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales of $22.47 ...